S-Nitrosoglutathione Attenuates Oxidative Stress and Improves Retention Memory Dysfunctions in Intra-Cerebroventricular-Streptozotocin Rat Model of Sporadic Alzheimer's Disease via Activation of BDNF and Nuclear Factor Erythroid 2-Related Factor-2 Antioxidant Signaling Pathway
- PMID: 38744261
- DOI: 10.1159/000538348
S-Nitrosoglutathione Attenuates Oxidative Stress and Improves Retention Memory Dysfunctions in Intra-Cerebroventricular-Streptozotocin Rat Model of Sporadic Alzheimer's Disease via Activation of BDNF and Nuclear Factor Erythroid 2-Related Factor-2 Antioxidant Signaling Pathway
Abstract
Introduction: The brain-derived neurotrophic factor (BDNF) and transcription nuclear factor erythroid 2-related factor-2 (NRF-2) play an important role in Alzheimer's disease (AD). However, the interactive involvement of BDNF and NRF-2 in respect to antioxidant mechanisms in different parts of the AD brain is still unclear. Considering the above condition, used S-nitrosoglutathione (GSNO) to examine whether it modulates the BDNF and NRF-2 levels to activate signaling pathway to promote antioxidant levels in AD brains.
Method: AD was induced by intracerebroventricular infusion of streptozotocin (ICV-STZ, 3 mg/kg) in Wistar rats. The effect of GSNO was analyzed by evaluating the retention of memory in months 1, 2, and 3. After the behavior study, rats were sacrificed and accessed the amyloid beta (Aβ)-40, Aβ42, glutathione (GSH), BDNF, and NRF-2 levels in the hippocampus, cortex, and amygdala tissue.
Results: Pretreatment with GSNO (50 µg/kg/intraperitoneal/day) restored the BDNF, and NRF-2 levels toward normalcy as compared with ICV-STZ + saline-treated animals. Also, GSNO treatment reversed the oxidative stress and increased the GSH levels toward normal levels. Further, reduced Aβ levels and neuronal loss in different brain regions. As a result, GSNO treatment improved the cognitive deficits in ICV-STZ-treated rats.
Conclusion: The results showed that endogenous nitric oxide donor GSNO improved the cognitive deficits and ICV-STZ-induced AD pathological conditions, possibly via attenuating the oxidative stress. Hence, the above finding supported that GSNO treatment may activate BDNF and NRF-2 antioxidant signaling pathways in the AD brain to normalize oxidative stress, which is the main causative factor for ICV-STZ-induced AD pathogenesis.
Keywords: Alzheimer’s disease; Amyloid beta; Intracerebroventricular infusion of streptozotocin; Nitric oxide; Nuclear factor erythroid 2-related factor-2 and brain-derived neurotrophic factor; S-nitrosoglutathione; Streptozotocin.
© 2024 S. Karger AG, Basel.
Similar articles
-
S-nitrosoglutathione modulates HDAC2 and BDNF levels in the brain and improves cognitive deficits in experimental model of Alzheimer's disease in rats.Int J Neurosci. 2024 Jul;134(7):777-785. doi: 10.1080/00207454.2022.2150190. Epub 2022 Dec 30. Int J Neurosci. 2024. PMID: 36408590
-
Amelioration by nitric oxide (NO) mimetics on neurobehavioral and biochemical changes in experimental model of Alzheimer's disease in rats.Neurotoxicology. 2018 May;66:58-65. doi: 10.1016/j.neuro.2018.03.001. Epub 2018 Mar 6. Neurotoxicology. 2018. PMID: 29522778
-
Protriptyline improves spatial memory and reduces oxidative damage by regulating NFκB-BDNF/CREB signaling axis in streptozotocin-induced rat model of Alzheimer's disease.Brain Res. 2021 Mar 1;1754:147261. doi: 10.1016/j.brainres.2020.147261. Epub 2021 Jan 7. Brain Res. 2021. PMID: 33422534
-
Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer's Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway.Neurotox Res. 2022 Apr;40(2):432-448. doi: 10.1007/s12640-022-00482-x. Epub 2022 Feb 22. Neurotox Res. 2022. Retraction in: Neurotox Res. 2024 Jul 15;42(4):34. doi: 10.1007/s12640-024-00713-3. PMID: 35192144 Retracted.
-
Bridging neurotrophic factors and bioactive peptides to Alzheimer's disease.Ageing Res Rev. 2024 Feb;94:102177. doi: 10.1016/j.arr.2023.102177. Epub 2023 Dec 22. Ageing Res Rev. 2024. PMID: 38142891 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials